Sunday, December 06, 2020 3:39:08 AM
The billion shares were part of the POR. BRTX coverted the debt into shares.what is a good thing.
The same for the warrants. Have you ever known a pharma company in this stage that could do all steps without money? LoL
BRTX is in talk with miltiple partners but if the deal is not what they want, they also have the possibility to do phase 2 themself. They don't need a partner.
Every day will add value to the company, converting the warrants will add more value than the diluting happening so stop scaring people.
The company now has no debt, starting phase 2, has patents worth over 100mil dollar (YES THEY HAVE) if they go current even worth more, BRTX will soon be current, has a multi billion dollar product in the pipeline, is in best position and shape ever, has the best people (mr. ALSTODT) in the right place. Moving in the right direction very fast, taking all the right steps and creating value for the company and stockholders.
Or would you rather have had that Desmarais took over the company and that the comons got whiped out?
Mr.Alstodt and Auctus made a great POR. He is holding 20mil shares and will not let the pps go down and loose his money. He doesn't need to save BRTX, but he wants to. He is already very rich and could as well enjoy the rest of his days sailing on his yacht.
O right and NASDAQ also coming without RS so you can be sure they have another very big surprice coming soon.
PLEASE CALL mr. ALSTODT he will be pleased to explain to you what is going on +630 760 8406
He told me he know there are people spreading misleading info and even lies on twitter and other mb but doesn't care. They are working hard and will create huge value for BRTX and the shareholders.
Now put that in a sticky
The same for the warrants. Have you ever known a pharma company in this stage that could do all steps without money? LoL
BRTX is in talk with miltiple partners but if the deal is not what they want, they also have the possibility to do phase 2 themself. They don't need a partner.
Every day will add value to the company, converting the warrants will add more value than the diluting happening so stop scaring people.
The company now has no debt, starting phase 2, has patents worth over 100mil dollar (YES THEY HAVE) if they go current even worth more, BRTX will soon be current, has a multi billion dollar product in the pipeline, is in best position and shape ever, has the best people (mr. ALSTODT) in the right place. Moving in the right direction very fast, taking all the right steps and creating value for the company and stockholders.
Or would you rather have had that Desmarais took over the company and that the comons got whiped out?
Mr.Alstodt and Auctus made a great POR. He is holding 20mil shares and will not let the pps go down and loose his money. He doesn't need to save BRTX, but he wants to. He is already very rich and could as well enjoy the rest of his days sailing on his yacht.
O right and NASDAQ also coming without RS so you can be sure they have another very big surprice coming soon.
PLEASE CALL mr. ALSTODT he will be pleased to explain to you what is going on +630 760 8406
He told me he know there are people spreading misleading info and even lies on twitter and other mb but doesn't care. They are working hard and will create huge value for BRTX and the shareholders.
Now put that in a sticky
Recent BRTX News
- BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform • GlobeNewswire Inc. • 04/21/2026 12:00:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/20/2026 09:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/13/2026 09:22:23 PM
- BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform • GlobeNewswire Inc. • 04/07/2026 12:15:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/03/2026 06:46:20 PM
- BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 03/30/2026 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 08:20:29 PM
- BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 03/19/2026 12:00:00 PM
- BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026 • GlobeNewswire Inc. • 03/05/2026 01:00:00 PM
- BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy • GlobeNewswire Inc. • 03/04/2026 01:00:00 PM
- BioRestorative secures Australian patent protection for ThermoStem® obesity therapy platform • IH Market News • 02/24/2026 03:14:07 PM
- BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs • GlobeNewswire Inc. • 02/24/2026 01:30:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/23/2026 09:50:39 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/18/2026 09:12:24 PM
- BioRestorative Announces Closing of $5.0 Million Public Offering • GlobeNewswire Inc. • 02/14/2026 01:30:00 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/13/2026 02:48:15 PM
- BioRestorative Announces Pricing of $5.0 Million Public Offering • GlobeNewswire Inc. • 02/12/2026 03:30:00 AM
- BioRestorative Announces Positive Outcome from Type B Meeting with FDA • GlobeNewswire Inc. • 02/11/2026 12:30:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/10/2026 10:20:59 PM
- BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 02/10/2026 01:00:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/09/2026 10:31:45 PM
